Literature DB >> 2999199

The alterations in pathogenicity and immunogenicity of a Kenya sheep and goat pox virus on serial passage in bovine foetal muscle cell cultures.

F G Davies, G Mbugwa.   

Abstract

A Kenyan sheep and goat pox virus was attenuated by serial passage in bovine foetal muscle cell cultures. The pathogenicity of the strain was lost between the 15th and 20th passages. Serum-neutralizing antibody developed after inoculation with passages tested up to the 50th. These passages appeared to protect animals against laboratory challenge by intra-dermal titration. The 18th passage was successfully and extensively used to control the disease under field conditions.

Entities:  

Mesh:

Year:  1985        PMID: 2999199     DOI: 10.1016/0021-9975(85)90026-x

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  9 in total

1.  The characterization of African strains of capripoxvirus.

Authors:  R P Kitching; P P Bhat; D N Black
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

Review 2.  Human poxvirus infection after the eradication of smallpox.

Authors:  D Baxby
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

3.  Sero-prevalence, risk factors and distribution of sheep and goat pox in Amhara Region, Ethiopia.

Authors:  Tsegaw Fentie; Nigusie Fenta; Samson Leta; Wassie Molla; Birhanu Ayele; Yechale Teshome; Seleshe Nigatu; Ashenafi Assefa
Journal:  BMC Vet Res       Date:  2017-12-11       Impact factor: 2.741

4.  Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus.

Authors:  Janika Wolff; Tom Moritz; Kore Schlottau; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Vaccines (Basel)       Date:  2020-12-23

Review 5.  Capripoxvirus Infections in Ruminants: A Review.

Authors:  Jihane Hamdi; Henry Munyanduki; Khalid Omari Tadlaoui; Mehdi El Harrak; Ouafaa Fassi Fihri
Journal:  Microorganisms       Date:  2021-04-23

6.  Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle.

Authors:  Serdar Uzar; Fahriye Sarac; Veli Gulyaz; Hakan Enul; Huseyin Yılmaz; Nuri Turan
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

7.  High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate.

Authors:  Janika Wolff; Martin Beer; Bernd Hoffmann
Journal:  Vaccines (Basel)       Date:  2022-06-27

8.  Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus.

Authors:  Eeva S M Tuppurainen; Caroline R Pearson; Katarzyna Bachanek-Bankowska; Nick J Knowles; Shadi Amareen; Lorraine Frost; Mark R Henstock; Charles E Lamien; Adama Diallo; Peter P C Mertens
Journal:  Antiviral Res       Date:  2014-06-25       Impact factor: 5.970

9.  Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle.

Authors:  Janika Wolff; Eeva Tuppurainen; Adeyinka Adedeji; Clement Meseko; Olayinka Asala; Jolly Adole; Rebecca Atai; Banenat Dogonyaro; Anja Globig; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Pathogens       Date:  2021-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.